is phentermine a glp 1 drug vs Ozempic Anti-Obesity medications (Mechanism of Action)

This article is for informational and educational purposes only

If you're going in and you're thinking that you're going to get really, really good weight loss, you're going to be disappointed, C

Priority review could shorten that window, but no priority designation has been granted yet

Proactive fertility planning: parallel assessments of fertility and metabolic risk should be conducted during the early 20s and 30s

Trujillo, J.M., Nuffer, W., and Smith, B.A

Tighter oversight of manufacturers pricing policies and the competitive environment Its unseemly (polite word choice) that the CEO of Lilly, Dave Ricks, is able to rake in total compensation of $114 million in 2024 while at the same time acknowledging that the price his company charges for Zepbound is too high. Unseemly, because his payday was fueled by Lilly making more than $10 billion in profit from GLP-1s in 2024 alone